Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard A Larson

Showing results (11-20 of 383) with videos related to

Pageof 39
Sort By:
Hematology. American Society of Hematology. Education Program|November 21, 2007
Etiology and management of therapy-related myeloid leukemiaRichard A Larson
Clinical Advances in Hematology & Oncology : H&O|September 16, 2005
Adult ALL: where are we and where are we going?Richard A Larson
Archives of Insect Biochemistry and Physiology|August 24, 2017
Plant defenses against oxidative stressRichard A Larson
Best Practice & Research. Clinical Haematology|March 7, 2006
Myelodysplasia: when to treat and howRichard A Larson
Leukemia & Lymphoma|May 24, 2017
Managing CNS disease in adults with acute lymphoblastic leukemiaRichard A Larson
Haematologica|April 2, 2009
Therapy-related myeloid neoplasmsRichard A Larson
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2012
Cytogenetics, not just previous therapy, determines the course of therapy-related myeloid neoplasmsRichard A Larson
Translational Pediatrics|February 3, 2016
Improving outcomes in childhood T-cell acute lymphoblastic leukemia: promising results from the Children's Oncology Group incorporating nelarabine into front-line therapyLori Muffly, Richard A Larson
Leukemia & Lymphoma|May 21, 2009
Discontinuing imatinib in chronic myeloid leukemia: don't try this at homeRyan Mattison, Richard A Larson
Oncology (Williston Park, N.Y.)|September 11, 2012
Acute myeloid leukemia: the challenge of unfavorable cytogeneticsGordana Raca, Richard A Larson
Pageof 39

Showing results (11-20 of 383) with videos related to

Sort By:
Pageof 39
Hematology. American Society of Hematology. Education Program|November 21, 2007
Etiology and management of therapy-related myeloid leukemiaRichard A Larson
Clinical Advances in Hematology & Oncology : H&O|September 16, 2005
Adult ALL: where are we and where are we going?Richard A Larson
Archives of Insect Biochemistry and Physiology|August 24, 2017
Plant defenses against oxidative stressRichard A Larson
Best Practice & Research. Clinical Haematology|March 7, 2006
Myelodysplasia: when to treat and howRichard A Larson
Leukemia & Lymphoma|May 24, 2017
Managing CNS disease in adults with acute lymphoblastic leukemiaRichard A Larson
Haematologica|April 2, 2009
Therapy-related myeloid neoplasmsRichard A Larson
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2012
Cytogenetics, not just previous therapy, determines the course of therapy-related myeloid neoplasmsRichard A Larson
Translational Pediatrics|February 3, 2016
Improving outcomes in childhood T-cell acute lymphoblastic leukemia: promising results from the Children's Oncology Group incorporating nelarabine into front-line therapyLori Muffly, Richard A Larson
Leukemia & Lymphoma|May 21, 2009
Discontinuing imatinib in chronic myeloid leukemia: don't try this at homeRyan Mattison, Richard A Larson
Oncology (Williston Park, N.Y.)|September 11, 2012
Acute myeloid leukemia: the challenge of unfavorable cytogeneticsGordana Raca, Richard A Larson
Pageof 39